Novitium Drug Patent Portfolio
Novitium owns 2 orange book drugs protected by 3 US patents Given below is the list of Novitium's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11878022 | Hydrochlorothiazide compositions | 23 Jan, 2044 | Active |
| US11224572 | Stable oral liquid composition of terazosin | 01 Feb, 2041 | Active |
| US12427108 | Stable Oral Liquid Composition Of Terazosin | 01 Feb, 2041 | Active |
Latest Legal Activities on Novitium's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Novitium.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Recordation of Patent Grant Mailed | 07 Oct, 2025 | US12427108 |
| Patent Issue Date Used in PTA Calculation | 30 Sep, 2025 | US12427108 |
| Mail Patent eGrant Notification | 30 Sep, 2025 | US12427108 |
| Patent eGrant Notification | 30 Sep, 2025 | US12427108 |
| Recordation of Patent eGrant | 30 Sep, 2025 | US12427108 |
| Email Notification | 30 Sep, 2025 | US12427108 |
| Email Notification | 18 Sep, 2025 | US12427108 |
| Issue Notification Mailed | 17 Sep, 2025 | US12427108 |
| Dispatch to FDC | 11 Sep, 2025 | US12427108 |
| Application Is Considered Ready for Issue | 11 Sep, 2025 | US12427108 |
| Issue Fee Payment Verified | 09 Sep, 2025 | US12427108 |
| Issue Fee Payment Received | 09 Sep, 2025 | US12427108 |
| Email Notification | 18 Jul, 2025 | US12427108 |
| Mail Notice of Allowance | 18 Jul, 2025 | US12427108 |
| Notice of Allowance Data Verification Completed | 17 Jul, 2025 | US12427108 |
Novitium's Family Patents
Recent FDA approvals and tentative approvals for Novitium
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Generic drugs
Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Pitolisant |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 24 Mar, 2026 |
Novitium Drug List
Given below is the complete list of Novitium's drugs and the patents protecting them.
1. Inzirqo
Inzirqo is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11878022 | Hydrochlorothiazide compositions |
23 Jan, 2044
(17 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Inzirqo's drug page
2. Tezruly
Tezruly is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11224572 | Stable oral liquid composition of terazosin |
01 Feb, 2041
(14 years from now)
| Active |
| US12427108 | Stable Oral Liquid Composition Of Terazosin |
01 Feb, 2041
(14 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tezruly's drug page